相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Value of Plasma Methylated SFRP2 in Prognosis of Gastric Cancer
Haijiao Yan et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Methylation status and long-fragment cell-free DNA are prognostic biomarkers for gastric cancer
Kazuhide Ko et al.
CANCER MEDICINE (2021)
TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer
Jia Li et al.
PEERJ (2021)
Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy
Meng Zhang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2021)
Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer
Dawei Ning et al.
MEDICAL SCIENCE MONITOR (2021)
Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer
Yuntao Shi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Circulating tumor DNA as an early cancer detection tool
Andrea Campos-Carrillo et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Identification of circulating tumor DNA using a targeted 545-gene next generation sequencing panel in patients with gastric cancer
Jing Lan et al.
ONCOLOGY LETTERS (2020)
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
Alessandro Leal et al.
NATURE COMMUNICATIONS (2020)
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
Jian Yang et al.
CELL DEATH & DISEASE (2020)
Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Bioniarker for Early Detection and Monitoring Progression of Gastric Cancer A Multiphase Study
Xin Guo et al.
JAMA SURGERY (2020)
Long noncoding RNAs in gastric cancer: From molecular dissection to clinical application
Yue Gao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
miR-212 as potential biomarker suppresses the proliferation of gastric cancer via targeting SOX4
Jian-Ping Shao et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Ryan Woodhouse et al.
PLOS ONE (2020)
HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery
Anna Grenda et al.
BMC GASTROENTEROLOGY (2020)
International liquid biopsy standardization alliance white paper
Dana Connors et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2-targeted therapies
Cheng Zhang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Mechanisms of Acquired Resistance to Savolitinib, a Selective MET Inhibitor in MET-Amplified Gastric Cancer
Melanie M. Frigault et al.
JCO PRECISION ONCOLOGY (2020)
CD44+ cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer
Antoni Szczepanik et al.
GASTRIC CANCER (2019)
Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
De-Shen Wang et al.
GUT (2019)
Tumor-specific genetic aberrations in cell-free DNA of gastroesophageal cancer patients
Kristina Magaard Koldby et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Exosomes in gastric cancer: roles, mechanisms, and applications
Min Fu et al.
MOLECULAR CANCER (2019)
The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer
Emne A. Abdallah et al.
ONCOLOGIST (2019)
Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer
Xiaomeng Jiang et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
The circulating transcriptome as a source of cancer liquid biopsy biomarkers
Carla Sole et al.
SEMINARS IN CANCER BIOLOGY (2019)
Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis
Yibo Fan et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer
Natasha B. Leighl et al.
CLINICAL CANCER RESEARCH (2019)
Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer
Yan Wang et al.
EBIOMEDICINE (2019)
Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer
Jianlin Chen et al.
PEERJ (2019)
Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancer
Young-Woo Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Enumeration And Characterization Of Circulating Tumor Cells And Its Application In Advanced Gastric Cancer
Boran Cheng et al.
ONCOTARGETS AND THERAPY (2019)
Chromosomal instability of circulating tumor DNA reflect therapeutic responses in advanced gastric cancer
Zuhua Chen et al.
CELL DEATH & DISEASE (2019)
Precision Medicine Tools to Guide Therapy and Monitor Response to Treatment in a HER-2+Gastric Cancer Patient: Case Report
Adriana Aguilar-Mahecha et al.
FRONTIERS IN ONCOLOGY (2019)
Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis
Yunhe Gao et al.
FRONTIERS IN ONCOLOGY (2019)
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?
Giuseppe Buono et al.
CANCER TREATMENT REVIEWS (2019)
Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas
Madiha Iabal et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer
Sahar Sarmasti Emami et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance
Yilin Li et al.
CLINICAL CANCER RESEARCH (2018)
Diagnostic Value of MicroRNA-18a for Gastric Cancer: a Meta-Analysis
Qindong Liang et al.
CLINICAL LABORATORY (2018)
Circulating microRNA-22-3p Predicts the Malignant Progression of Precancerous Gastric Lesions from Intestinal Metaplasia to Early Adenocarcinoma
Tsung-Hsing Chen et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer
Haixing Wang et al.
EUROPEAN JOURNAL OF CANCER (2018)
Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer
Chaogang Yang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer
Rui Zhao et al.
MOLECULAR CANCER (2018)
Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer
Ling-Yun Lin et al.
MOLECULAR CANCER (2018)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
Liquid biopsy provides new insights into gastric cancer
Camila Tavares Uchôa Guimarães et al.
Oncotarget (2018)
Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression
Furong Wang et al.
ONCOGENESIS (2018)
Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy
Chunyan Yue et al.
ONCOIMMUNOLOGY (2018)
CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer
Weiwei Tang et al.
MOLECULAR CANCER (2018)
MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives
Alexander Link et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Circulating long non-coding RNAs HULC and ZNFX1-AS1 are potential biomarkers in patients with gastric cancer
Hai-Peng Xian et al.
ONCOLOGY LETTERS (2018)
Latest development of liquid biopsy
Alvin Ho-Kwan Cheung et al.
JOURNAL OF THORACIC DISEASE (2018)
Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration
Xu Zhang et al.
MOLECULAR CANCER (2018)
Diagnostic and prognostic value of circulating lncRNA H19 in gastric cancer
Ebru Esin Yoruker et al.
BIOMEDICAL REPORTS (2018)
Mesothelial Cells Create a Novel Tissue Niche That Facilitates Gastric Cancer Invasion
Masamitsu Tanaka et al.
CANCER RESEARCH (2017)
Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application
Fangfang Chen et al.
ONCOTARGET (2017)
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects
Simon Pernot et al.
EUROPEAN JOURNAL OF CANCER (2017)
Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier
Guang Deng et al.
FEBS LETTERS (2017)
Circulating tumor cells detected by lab-on-adisc: Role in early diagnosis of gastric cancer
Hwa Mi Kang et al.
PLOS ONE (2017)
Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients
Yuji Mishima et al.
TARGETED ONCOLOGY (2017)
Circulating microRNA-196a is an early gastric cancer biomarker
Tsung-Hsing Chen et al.
Oncotarget (2017)
Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer
Hsiao-Wei Kao et al.
ONCOTARGET (2017)
Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification
Juan Du et al.
ONCOTARGET (2017)
A serum exosomal microRNA panel as a potential biomarker test for gastric cancer
Ning Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Prognostic value of circulating tumor cells in advanced gastric cancer patients receiving chemotherapy
Yongping Liu et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer
Hiroki Imaoka et al.
GASTRIC CANCER (2016)
Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
Yilin Li et al.
BRITISH JOURNAL OF CANCER (2016)
Circulating tumor cells are predictive of poor response to chemotherapy in metastatic gastric cancer
Su Jin Lee et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2015)
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association
Hideaki Shimada et al.
GASTRIC CANCER (2014)
Clinical relevance of circulating cell-free microRNAs in cancer
Heidi Schwarzenbach et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Circulating Tumor Cells (CTCs) Detected by RT-PCR and Its Prognostic Role in Gastric Cancer: A Meta-Analysis of Published Literature
Shuyi Wang et al.
PLOS ONE (2014)
Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer
A. Shiotani et al.
BRITISH JOURNAL OF CANCER (2013)
Recent advances on the role of tumor exosomes in immunosuppression and disease progression
Paola Filipazzi et al.
SEMINARS IN CANCER BIOLOGY (2012)
Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer
Leticia De Mattos-Arruda et al.
FUTURE ONCOLOGY (2011)
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
Andrew J. Armstrong et al.
MOLECULAR CANCER RESEARCH (2011)
Predictive Value of Serum CEA, CA19-9 and CA72.4 in Early Diagnosis of Recurrence after Radical Resection of Gastric Cancer
Yan Li et al.
HEPATO-GASTROENTEROLOGY (2011)
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
Satoshi Matsusaka et al.
CANCER SCIENCE (2010)
Circulating Tumor Cells in Colorectal Cancer: Past, Present, and Future Challenges
Benjamin P. Negin et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2010)
Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using a Differential Secretome Approach
Hua Xue et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Circulating tumour cells in cancer patients: challenges and perspectives
Klaus Pantel et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Cuantificación inmunomagnética de células tumorales circulantes en pacientes con cáncer de próstata: correlación clínica y patológica
L. Resel Folkersma et al.
ARCHIVOS ESPANOLES DE UROLOGIA (2010)
Microvesicles Messengers and mediators of tumor progression
Khalid Al-Nedawi et al.
CELL CYCLE (2009)
Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation
J. -L. Qu et al.
DIGESTIVE AND LIVER DISEASE (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Tumour-released exosomes and their implications in cancer immunity
M. Iero et al.
CELL DEATH AND DIFFERENTIATION (2008)
Tumor-released microvesicles as vehicles of immunosuppression
Roberta Valenti et al.
CANCER RESEARCH (2007)
Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication
J. Ratajczak et al.
LEUKEMIA (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
